Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity.
Sabatino JJ Jr, Mittl K, Rowles W, Mcpolin K, Rajan JV, Zamecnik CR, Dandekar R, Alvarenga BD, Loudermilk RP, Gerungan C, Spencer CM, Sagan SA, Augusto DG, Alexander J, Hollenbach JA, Wilson MR, Zamvil SS, Bove R.
Sabatino JJ Jr, et al. Among authors: sagan sa.
medRxiv [Preprint]. 2021 Sep 20:2021.09.10.21262933. doi: 10.1101/2021.09.10.21262933.
medRxiv. 2021.
PMID: 34580672
Free PMC article.
Updated.
Preprint.